These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25796743)

  • 1. [Measurement of sitafloxacin MIC for Mycobacterium avium complex and application for treatment of pulmonary nontuberculous mycobacteriosis].
    Fujita M; Matsumoto T; Hirano R; Harada E; Ikegame S; Nakanishi Y; Watanabe K
    Jpn J Antibiot; 2014 Dec; 67(6):395-400. PubMed ID: 25796743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of sitafloxacin against clinical isolates in 2012].
    Amano A; Matsuzaki K; Kishi N; Koyama H; Hasegawa M; Ikeda F; Matsumoto T; Yamaguchi H; Okutani Y
    Jpn J Antibiot; 2013 Dec; 66(6):311-30. PubMed ID: 24649797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of sitafloxacin against clinical isolates in 2009].
    Amano A; Matsuzaki K; Kishi N; Saika T; Hasegawa M; Ikeda F; Matsumoto T; Yamaguchi H; Kanda Y; Shiozawa T
    Jpn J Antibiot; 2010 Dec; 63(6):411-30. PubMed ID: 21425595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection.
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E
    J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium.
    Sano C; Tatano Y; Shimizu T; Yamabe S; Sato K; Tomioka H
    Int J Antimicrob Agents; 2011 Apr; 37(4):296-301. PubMed ID: 21353489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Tomioka H; Sato K; Akaki T; Kajitani H; Kawahara S; Sakatani M
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3001-4. PubMed ID: 10582897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
    Fujita M; Kajiki A; Tao Y; Miyazaki M; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
    J Infect Chemother; 2012 Apr; 18(2):146-51. PubMed ID: 21927844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility test of the Mycobacterium avium complex to sixteen anti-infective agents].
    Duan HF; Doi N; Li Q; Ma Y; Chen XY; Fu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 May; 33(5):359-62. PubMed ID: 20646615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
    Kohno Y; Ohno H; Miyazaki Y; Higashiyama Y; Yanagihara K; Hirakata Y; Fukushima K; Kohno S
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4071-6. PubMed ID: 17709469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
    Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of sitafloxacin against atypical bacteria (2009-2014) and comparison between susceptibility of clinical isolates in 2009 and 2012.
    Amano A; Kishi N; Koyama H; Matsuzaki K; Matsumoto S; Uchino K; Yamaguchi H; Yokomizo A; Mizuno M
    Jpn J Antibiot; 2016 Sep; 69(3):131-142. PubMed ID: 30226949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.
    Cai S; Sato K; Shimizu T; Yamabe S; Hiraki M; Sano C; Tomioka H
    J Antimicrob Chemother; 2006 Jan; 57(1):85-93. PubMed ID: 16303883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex.
    Tomioka H; Sano C; Sato K; Shimizu T
    Int J Antimicrob Agents; 2002 Feb; 19(2):139-45. PubMed ID: 11850167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sitafloxacin-Containing Regimen for the Treatment of Refractory
    Asakura T; Suzuki S; Fukano H; Okamori S; Kusumoto T; Uwamino Y; Ogawa T; So M; Uno S; Namkoong H; Yoshida M; Kamata H; Ishii M; Nishimura T; Hoshino Y; Hasegawa N
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz108. PubMed ID: 31111076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary Evaluation of a Sitafloxacin-Containing Regimen for Relapsed or Refractory Pulmonary
    Fujita K; Fujita M; Ito Y; Hirai T; Mio T; Watanabe K; Mishima M
    Open Forum Infect Dis; 2016 Sep; 3(3):ofw147. PubMed ID: 27704005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration.
    Rodríguez JC; Cebrián L; López M; Ruiz M; Royo G
    Int J Antimicrob Agents; 2005 Mar; 25(3):221-5. PubMed ID: 15737516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.